| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-07 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |